In the article "Risks and benefits of clopidogrel–aspirin in minor stroke or TIA: Time course analysis of CHANCE” by Y. Pan et al.,1 there are errors in table 1 for “Moderate to severe bleeding” events in both the ASA and CLP + ASA treatment groups. The corrected table 1 is posted below with changes in bold type. Accordingly, the passage on page 1908 should read “A total of 6 moderate to severe bleedings occurred within the first month in the clopidogrel-aspirin group with 3 during the first week… Only 2 moderate to severe bleedings occurred during the first week of the first month in the aspirin alone group” rather than “A total of 4 moderate to severe bleedings occurred within the first month in the clopidogrel-aspirin group with 1 during the first week… No moderate to severe bleeding occuring within the first month in the aspirin alone group” as originally published. The authors regret the errors.
Time course distribution of ischemic stroke and bleeding by treatment assignment
- © 2019 American Academy of Neurology
Reference
- 1.↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Alert Me
Recommended articles
Risks and benefits of clopidogrel–aspirin in minor stroke or TIA
Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke
F2R Polymorphisms and Clopidogrel Efficacy and Safety in Patients With Minor Stroke or TIA
Adding aspirin to clopidogrel after TIA and ischemic stroke